ConductScience.org, home

Paper11680576

Compliance with therapy in patients with chronic hepatitis C: associations with psychiatric symptoms, interpersonal problems, and mode of acquisition.

Kraus MR and 5 others. Dig Dis Sci, 2001. Cited by 63 papers, by iCite.

Cite this record

ConductScience Library. Compliance with therapy in patients with chronic hepatitis C: associations with psychiatric symptoms, interpersonal problems, and mode of acquisition. Papers, record 11680576. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11680576

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Compliance with therapy in patients with chronic hepatitis C: associations with psychiatric symptoms, interpersonal problems, and mode of acquisition.
PubMed
Journal
Dig Dis Sci
PubMed
Year
2001
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
63
iCite
Relative citation ratio, by iCite
1.98
iCite
Revised in PubMed
2026-10-16
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kraus MRM R
2Schäfer AA
3Csef HH
4Faller HH
5Mörk HH
6Scheurlen MM

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiviral AgentsMajor topic
Hepatitis C, ChronicMajor topic
Interferon-alphaMajor topic
Patient ComplianceMajor topic
PersonalityMajor topic
Adolescent
Adult
Aged
Drug Therapy, Combination
Emotions
Female
Humans
Interferon alpha-2
Interpersonal Relations
Male
Middle Aged
Psychometrics
Recombinant Proteins
Ribavirin
Sensitivity and Specificity

Source PubMed

Download CSV of topics

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19600005[Determinants of high risk illness behavior in patients with bronchial asthma].Psychother Psychosom Med Psychol1998https://conductscience.org/library/papers/9600005PubMed
210593141[Validation of the Inventory for Interpersonal Problems (IIP). Results of a representative study in East and West Germany].Psychother Psychosom Med Psychol1999https://conductscience.org/library/papers/10593141PubMed
37589375The psychological factors associated with poor compliance with treatment in asthma.Eur Respir J1995https://conductscience.org/library/papers/7589375PubMed
49846389Medication compliance in patients with chronic schizophrenia: implications for the community management of mentally disordered offenders.J Forensic Sci1998https://conductscience.org/library/papers/9846389PubMed
511015623Emotional state, coping styles, and somatic variables in patients with chronic hepatitis C.Psychosomatics2000https://conductscience.org/library/papers/11015623PubMed
62758726Time to stop counting the tablets?Clin Pharmacol Ther1989https://conductscience.org/library/papers/2758726PubMed
79453751[Acceptance of, compliance with and tolerance to antiretroviral treatment in patients with human immunodeficiency virus infection].An Med Interna1997https://conductscience.org/library/papers/9453751PubMed
89050360Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-1b: relationship to adherence to treatment.Mult Scler1996https://conductscience.org/library/papers/9050360PubMed
99006219The cognitive orientation of compliance in short- and long-term type 2 diabetic patients.Patient Educ Couns1996https://conductscience.org/library/papers/9006219PubMed
109987757Side effect profile and adherence to in the treatment of multiple sclerosis with interferon beta-1a.Mult Scler1998https://conductscience.org/library/papers/9987757PubMed
119116538Compliance becomes concordance.BMJ1997https://conductscience.org/library/papers/9116538PubMed
1210509579Sociodemographic and psychological variables influencing adherence to antiretroviral therapy.AIDS1999https://conductscience.org/library/papers/10509579PubMed
139224151Compliance and concordance with treatment. Coming to an understanding with patients and prepositions.BMJ1997https://conductscience.org/library/papers/9224151PubMed
148958898Evaluation of a directly observed six months fully intermittent treatment regimen for tuberculosis in patients suspected of poor compliance.Thorax1996https://conductscience.org/library/papers/8958898PubMed
1510480277Locus of control beliefs predicting oral and diabetes health behavior and health status.Acta Odontol Scand1999https://conductscience.org/library/papers/10480277PubMed
1610493464Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy.Med Care1999https://conductscience.org/library/papers/10493464PubMed
179305666Epidemiology of hepatitis C.Hepatology1997https://conductscience.org/library/papers/9305666PubMed
189819446Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.N Engl J Med1998https://conductscience.org/library/papers/9819446PubMed
198190855Implications of directly observed therapy in tuberculosis control measures among IDUs.Public Health Rep1994https://conductscience.org/library/papers/8190855PubMed
209807989
Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT)
Lancet1998https://conductscience.org/library/papers/9807989PubMed

Download CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.

PMIDTitleJournalYearIn PapersSource
33813925Barriers to Completing Therapy for Hepatitis C with Direct-Acting Antivirals: A Real-Life Experience from a Single Treatment Center in Egypt.J Prim Care Community Health2021https://conductscience.org/library/papers/33813925PubMed
28533742Depression and Chronic Liver Diseases: Are There Shared Underlying Mechanisms?Front Mol Neurosci2017https://conductscience.org/library/papers/28533742PubMed
26576086Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015.World J Gastroenterol2015https://conductscience.org/library/papers/26576086PubMed
25977607Hepatitis infection in the treatment of opioid dependence and abuse.Subst Abuse2008https://conductscience.org/library/papers/25977607PubMed
25688295Management of Adverse Events During the Treatment of Chronic Hepatitis C Infection.Clin Liver Dis (Hoboken)2012https://conductscience.org/library/papers/25688295PubMed
24204676Can antidepressants prevent pegylated interferon-α/ribavirin-associated depression in patients with chronic hepatitis C: meta-analysis of randomized, double-blind, placebo-controlled trials?PLoS One2013https://conductscience.org/library/papers/24204676PubMed
23329897The practical management of treatment failure in chronic hepatitis C: a summary of current research and management options for refractory patients.Gastroenterol Hepatol (N Y)2007https://conductscience.org/library/papers/23329897PubMed
22353759Neurobehavioral effects of interferon-α in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine.Neuropsychopharmacology2012https://conductscience.org/library/papers/22353759PubMed
21917781The cost-effectiveness of telestroke in the treatment of acute ischemic stroke.Neurology2011https://conductscience.org/library/papers/21917781PubMed
21654873Risk factors for the development of depression in patients with hepatitis C taking interferon-α.Neuropsychiatr Dis Treat2011https://conductscience.org/library/papers/21654873PubMed
21248044Coevolution of the hepatitis C virus polyprotein sites in patients on combined pegylated interferon and ribavirin therapy.J Virol2011https://conductscience.org/library/papers/21248044PubMed
21246281The role of patient religiosity in the evaluation and treatment outcomes for chronic HCV infection.J Relig Health2013https://conductscience.org/library/papers/21246281PubMed
19122126Psychosocial issues in hepatitis C: a qualitative analysis.Psychosomatics2008https://conductscience.org/library/papers/19122126PubMed
18721241Changes in mood states and biomarkers during peginterferon and ribavirin treatment of chronic hepatitis C.Am J Gastroenterol2008https://conductscience.org/library/papers/18721241PubMed
16930214Barriers to treatment of hepatitis C in HIV/HCV-coinfected adults with alcohol problems.Alcohol Clin Exp Res2006https://conductscience.org/library/papers/16930214PubMed
16451091Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and management.Drugs2006https://conductscience.org/library/papers/16451091PubMed
15793861Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C.World J Gastroenterol2005https://conductscience.org/library/papers/15793861PubMed
15669887Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction.J Clin Psychiatry2005https://conductscience.org/library/papers/15669887PubMed
15554429Central nervous system involvement in hepatitis C virus infection.Metab Brain Dis2004https://conductscience.org/library/papers/15554429PubMed
12679925Effect of alpha 2b interferon on inducement of mIL-2R and treatment of HCV in PBMC from patients with chronic viral hepatitis C.World J Gastroenterol2003https://conductscience.org/library/papers/12679925PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IFNA23440PubTator's text mininghttps://conductscience.org/library/genes/3440

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11680576

GET https://conductscience.org/api/papers/v1/11680576/authors